Skip to main content
Equibles
CSBR logo

CSBR · Champions Oncology, Inc. · Earnings Call Transcripts & Audio

Track CSBR — free

Use CSBR with AI

Add company filings, earnings and prices to ChatGPT or Claude, then ask questions in your own chat.

Choose your app for step-by-step connection instructions. Sign in with Equibles when asked; no code or API key is needed.

Claude ChatGPT

After connecting, ask your AI to use Equibles to research CSBR.

Other apps & server URL
https://mcp.equibles.com/mcp
Gemini CLI setup
or ask here

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

See what you can ask in ChatGPT or Claude

All connection guides →
$4.92 -0.18 (-3.53%) At close · Sep 14
Rebalance outlook locked
Market Cap
$69.73M
Shares
13.92M

Champions Oncology, Inc. Earnings Call Transcripts

Quarterly earnings calls for Champions Oncology, Inc. (CSBR), with available speaker-labelled transcripts, captured audio replays, call highlights, 8-K earnings releases and periodic filings. Investor days and conferences appear here too.

Pull transcripts and briefs through the earnings call transcript API or MCP →

Revenue & result across quarters

Revenue Net income YoY up YoY down artefacts
▲21.2% $14.28M −$16,000 '23 Q2 22-12-13 ▼3.2% $12.77M −$2.44M '23 Q3 23-03-15 ▲1.5% $13.07M −$2.56M '23 Q4 23-07-24 ▼8.6% $12.56M −$2.57M '24 Q1 23-09-13 ▼19% $11.57M −$2.07M '24 Q2 23-12-12 ▼5.9% $12.02M −$2.53M '24 Q3 24-03-12 ▲7.1% $14.00M −$109,000 '24 Q4 24-07-18 ▲11.9% $14.06M $1.31M '25 Q1 24-09-11 ▲16.6% $13.49M $728,000 '25 Q2 24-12-11 ▲41.8% $17.04M $4.50M '25 Q3 25-03-11 ▼11.8% $12.36M −$1.83M '25 Q4 25-07-23 ▼0.5% $13.99M −$466,000 '26 Q1 25-09-15 ▲11.5% $15.04M $268,000 '26 Q2 25-12-15 ▼2.8% $16.56M −$279,000 '26 Q3 26-03-12 ▲12% $13.84M −$698,000 '26 Q4 26-07-27 LATEST ▲8.8% $15.23M −$426,000 '27 Q1 26-09-10
Earnings call
FY27 · Q1
2026-09-10
Champions Oncology, Inc. (CSBR) Q1 2027 Earnings Call
Revenue
$15.23M
▲ 8.8% YoY
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY26 · Q4
2026-07-27
Champions Oncology, Inc. (CSBR) Q4 2026 Earnings Call
Revenue
$13.84M*
▲ 12% YoY
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-K
Earnings call
FY26 · Q3
2026-03-12
Champions Oncology, Inc. (CSBR) Q3 2026 Earnings Call Transcript
Positive tone Services revenue growth and operational performance Data business momentum and pipeline Investment in data platform and Discovery Therapeutics
Revenue
$16.56M
▼ 2.8% YoY
Diluted EPS
$-0.02
▼ 106.5% YoY
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY26 · Q2
2025-12-15
Champions Oncology, Inc. (CSBR) Q2 2026 Earnings Call Transcript
Confident tone Revenue growth and bookings momentum Corellia subsidiary and VC funding Data platform and strategic hires
Revenue
$15.04M
▲ 11.5% YoY
Diluted EPS
$0.02
▼ 60% YoY
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY26 · Q1
2025-09-15
Champions Oncology, Inc. (CSBR) Q1 2026 Earnings Call Transcript
Positive tone Data platform / AI & ML licensing Corellia drug discovery subsidiary Margin expansion and cost management
Revenue
$13.99M
▼ 0.5% YoY
Diluted EPS
$-0.03
▼ 133.3% YoY
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY25 · Q4
2025-07-23
Champions Oncology, Inc. (CSBR) Q4 2025 Earnings Call Transcript
Confident tone Data licensing platform Turnaround and return to profitability Core research services business
Revenue
$12.36M*
▼ 11.8% YoY
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-K
Earnings call
FY25 · Q3
2025-03-11
Champions Oncology, Inc. (CSBR) Q3 2025 Earnings Call Transcript
Confident tone PDX bank and multiomic data asset Data licensing platform launch Record Q3 financial results
Revenue
$17.04M
▲ 41.8% YoY
Diluted EPS
$0.31
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY25 · Q2
2024-12-11
Champions Oncology, Inc. (CSBR) Q2 2025 Earnings Call Transcript
Confident tone Quarterly Financial Performance Balance Sheet / Cash Position Corellia Drug Development Subsidiary
Revenue
$13.49M
▲ 16.6% YoY
Diluted EPS
$0.05
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY25 · Q1
2024-09-11
Champions Oncology, Inc. (CSBR) Q1 2025 Earnings Call Transcript
Confident tone Revenue Growth Financial Turnaround and Profitability Biotech Funding Environment
Revenue
$14.06M
▲ 11.9% YoY
Diluted EPS
$0.09
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY24 · Q4
2024-07-18
Champions Oncology, Inc. (CSBR) Q4 2024 Earnings Call Transcript
Positive tone Strategic focus on big pharma / top-tier customers Ex-vivo platform growth and expansion Operational improvements and scaling
Revenue
$14.00M*
▲ 7.1% YoY
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-K
Earnings call
FY24 · Q3
2024-03-12
Champions Oncology, Inc. (CSBR) Q3 2024 Earnings Call Transcript
Positive tone Revenue and Bookings Recovery Biotech Sector Headwinds Corellia Drug Discovery
Revenue
$12.02M
▼ 5.9% YoY
Diluted EPS
$-0.19
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY24 · Q2
2023-12-12
Champions Oncology, Inc. (CSBR) Q2 2024 Earnings Call Transcript
Revenue
$11.57M
▼ 19% YoY
Diluted EPS
$-0.15
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY24 · Q1
2023-09-13
Champions Oncology, Inc. (CSBR) Q1 2024 Earnings Call Transcript
Revenue
$12.56M
▼ 8.6% YoY
Diluted EPS
$-0.19
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY23 · Q4
2023-07-24
Champions Oncology, Inc. (CSBR) Q4 2023 Earnings Call Transcript
Revenue
$13.07M*
▲ 1.5% YoY
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-K
Earnings call
FY23 · Q3
2023-03-15
Champions Oncology, Inc. (CSBR) Q3 2023 Earnings Call Transcript
Revenue
$12.77M
▼ 3.2% YoY
Diluted EPS
$-0.18
▼ 460% YoY
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY23 · Q2
2022-12-13
Champions Oncology, Inc. (CSBR) Q2 2023 Earnings Call Transcript
Revenue
$14.28M
▲ 21.2% YoY
Diluted EPS
$0.00
▼ 100% YoY
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY23 · Q1
2022-09-08
Champions Oncology, Inc. (CSBR) Q1 2023 Earnings Call Transcript
Revenue
$13.74M
▲ 22.1% YoY
Diluted EPS
$-0.02
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY22 · Q4
2022-07-21
Champions Oncology, Inc. (CSBR) Q4 2022 Earnings Call Transcript
Revenue
$12.88M*
▲ 21.9% YoY
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-K
Earnings call
FY22 · Q3
2022-03-15
Champions Oncology, Inc. (CSBR) Q3 2022 Earnings Call Transcript
Revenue
$13.19M
▲ 22% YoY
Diluted EPS
$0.05
▼ 28.6% YoY
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY22 · Q2
2021-12-13
Champions Oncology, Inc. (CSBR) Q2 2022 Earnings Call Transcript
Revenue
$11.79M
▲ 16.5% YoY
Diluted EPS
$0.02
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY22 · Q1
2021-09-13
Champions Oncology, Inc. (CSBR) Q1 2022 Earnings Call Transcript
Revenue
$11.25M
▲ 17.9% YoY
Diluted EPS
$-0.01
▼ 200% YoY
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY21 · Q4
2021-07-22
Champions Oncology, Inc. (CSBR) Q4 2021 Earnings Call Transcript
Revenue
$10.56M*
▲ 20.7% YoY
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-K
Earnings call
FY21 · Q3
2021-03-11
Champions Oncology, Inc. (CSBR) Q3 2021 Earnings Call Transcript
Revenue
$10.81M
▲ 20% YoY
Diluted EPS
$0.07
▲ 133.3% YoY
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY21 · Q2
2020-12-14
Champions Oncology, Inc. (CSBR) Q2 2021 Earnings Call Transcript
Revenue
$10.12M
▲ 32.7% YoY
Diluted EPS
$0.00
▼ 100% YoY
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY21 · Q1
2020-09-14
Champions Oncology, Inc. (CSBR) Q1 2021 Earnings Call Transcript
Revenue
$9.55M
▲ 41.7% YoY
Diluted EPS
$0.01
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY20 · Q4
2020-07-27
Champions Oncology, Inc. (CSBR) Q4 2020 Earnings Call Transcript
Revenue
$8.75M*
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-K
Earnings call
FY20 · Q3
2020-03-12
Champions Oncology, Inc. (CSBR) Q3 2020 Earnings Call Transcript
Revenue
$9.01M
▲ 40.2% YoY
Diluted EPS
$0.03
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY20 · Q2
2019-10-31
Champions Oncology, Inc. (CSBR) Q2 2020 Earnings Call Transcript
Revenue
$7.62M
▲ 13.9% YoY
Diluted EPS
$0.02
▲ 0% YoY
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Showing 1–28 of 28 earnings calls
Key facts CIK 771856 CUSIP 15870P307 13F (30d) 2 filings 2 filers Visit website Investor relations